Preclinical Efficacy Comparison of Cyclosporine Ophthalmic Solution 0.09% vs Cyclosporine Ophthalmic Emulsion 0.05% vs Ciclosporin Ophthalmic Emulsion 0.1% in a NOD Mouse Model of Dry Eye Disease

INTRODUCTION: Cyclosporine ophthalmic solution 0.09% (CsA 0.09% sol) is approved to increase tear production in patients with keratoconjunctivitis sicca. This study evaluated the efficacy of CsA 0.09% sol vs cyclosporine ophthalmic emulsion 0.05% (CsA 0.05% eml) vs ciclosporin ophthalmic emulsion 0....

Descripción completa

Detalles Bibliográficos
Autores principales: Burade, Vinod, Zalawadia, Rishit, Patel, Alpesh, Ogundele, Abayomi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7518773/
https://www.ncbi.nlm.nih.gov/pubmed/33061257
http://dx.doi.org/10.2147/OPTH.S259331

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7518773/
https://www.ncbi.nlm.nih.gov/pubmed/33061257
http://dx.doi.org/10.2147/OPTH.S259331

Ejemplares similares